These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21738743)

  • 21. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
    Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
    Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes.
    Zhao Z; Jinde S; Koike S; Tada M; Satomura Y; Yoshikawa A; Nishimura Y; Takizawa R; Kinoshita A; Sakakibara E; Sakurada H; Yamagishi M; Nishimura F; Inai A; Nishioka M; Eriguchi Y; Araki T; Takaya A; Kan C; Umeda M; Shimazu A; Hashimoto H; Bundo M; Iwamoto K; Kakiuchi C; Kasai K
    Transl Psychiatry; 2019 Nov; 9(1):289. PubMed ID: 31712567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.
    Zhuo X; Zhou W; Li D; Chang A; Wang Y; Wu Y; Zhou Q
    Cancer Biomark; 2018; 23(4):579-587. PubMed ID: 30475754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria.
    Kaur H; Sehgal R; Kumar A; Sehgal A; Bansal D; Sultan AA
    J Transl Med; 2018 Oct; 16(1):272. PubMed ID: 30286756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.
    Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W
    Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression levels of plasma microRNA in Hashimoto's disease.
    Zhao L; Zhou X; Shan X; Qi LW; Wang T; Zhu J; Zhu D; Huang Z; Zhang L; Zhang H; Yin Y; Wang Z; Zhu W; Cheng W; Jiang L
    Gene; 2018 Feb; 642():152-158. PubMed ID: 29054761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
    Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
    J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating aberrantly expressed microRNAs in peripheral blood mononuclear cells from patients with treatment‑resistant schizophrenia using miRNA sequencing and integrated bioinformatics.
    You X; Zhang Y; Long Q; Liu Z; Ma X; Lu Z; Yang W; Feng Z; Zhang W; Teng Z; Zeng Y
    Mol Med Rep; 2020 Nov; 22(5):4340-4350. PubMed ID: 33000265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes.
    Yan S; Wang T; Huang S; Di Y; Huang Y; Liu X; Luo Z; Han W; An B
    Acta Diabetol; 2016 Oct; 53(5):693-702. PubMed ID: 27039347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
    Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
    Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
    Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.